Characterization of the integrin alpha v beta3 in arteriovenous malformations and cavernous malformations.
BACKGROUND
Alpha V beta 3 (alphavbeta3) is an integrin specifically expressed on the endothelial cells of central nervous system (CNS) neoplasms. However, no data exist on the expression of alphavbeta3 in vascular malformations of the CNS. In this study, we investigate the expression of alphavbeta3 in arteriovenous malformations (AVMs) and cavernous malformations (CMs).


METHODS
Frozen samples of AVMs from 12 patients and CMs from 5 patients were obtained intraoperatively. Once the final pathology had been confirmed, immunohistochemistry was performed using an antibody to the integrin alphavbeta3. The alphavbeta3 expression pattern was graded according to the percentage of positively staining vessels.


RESULTS
Ten of 12 AVMs demonstrated alphavbeta3 immunopositivity. Six of these 10 AVMs had moderate or strong staining. Most notably, 5 of the 6 moderate or strongly staining AVMs came from patients 22 years of age or younger. Four of these 6 AVMs had previously been embolized. None of the cavernous malformations demonstrated alphavbeta3 immunopositivity.


CONCLUSIONS
alphavbeta3 may contribute to the formation of AVMs in younger patients. alphavbeta3 may also provide a potential therapeutic target. The lack of alphavbeta3 expression in cavernous malformations, despite their high vascular densities, suggests that the pathophysiology of their formation differs from that of AVMs.
Lim
Michael
M
Department of Neurosurgery, Stanford University, Stanford, CA 94305-5488, USA.
Haddix
Terri
T
Harsh
Griffith R
GR
Vogel
Hannes
H
Steinberg
Gary K
GK
Guccione
Samira
S
D000293:Adolescent; D000328:Adult; D001165:Arteriovenous Malformations / Q000097:blood* / Q000473:pathology / Q000601:surgery; D002560:Cerebrovascular Circulation; D002648:Child; D004730:Endothelium, Vascular / Q000503:physiopathology; D006801:Humans; D039302:Integrin alphaVbeta3 / Q000097:blood*; D008875:Middle Aged; D012189:Retrospective Studies
D039302:Integrin alphaVbeta3